Bicalutamide 50mg Tablets | Bicalumutide

 

Bicalutamide 50 mg tablet treats prostate cancer in men. This non-steroidal anti-androgen blocks testosterone receptors in prostate cancer cells, stopping the hormonal signal that drives tumor growth. It is prescribed either alone or alongside LHRH analogues for locally advanced and metastatic prostate cancer management. Bicalutamide 50 mg reduces PSA levels effectively. Clinically validated across global oncology protocols, this once-daily oral tablet offers effective tumor control while preserving better quality of life compared to surgical castration. Bicalumutide 50 by Steris Healthcare delivers this trusted therapy with WHO-GMP certified quality.

What Is Bicalutamide 50 mg Tablet Used For?

Bicalutamide 50 mg tablet treats prostate cancer in adult men. Marketed as Bicalumutide 50 by Steris Healthcare Pvt Ltd, this anti-androgen medicine is prescribed to block male hormones (androgens) that fuel the growth of prostate cancer cells. It is used either alone or in combination with other hormonal therapies like LHRH analogues for effective prostate cancer management.

Doctors prescribe Bicalumutide 50 for:

• Treatment of locally advanced prostate cancer as monotherapy

• Combined hormonal therapy alongside LHRH agonists for metastatic prostate cancer

• Reducing the risk of disease progression in early-stage prostate cancer patients

• Managing rising PSA (Prostate-Specific Antigen) levels after primary treatment

• Palliative treatment in men where surgery or radiation is not suitable

Key Product Details:

• Brand Name: Bicalumutide 50 (Steris Healthcare Pvt Ltd)
• Composition Name: Bicalutamide
• Strength: 50 mg per tablet
• Formulation: Film-coated immediate-release tablet
• Pack Size: Strip of 10 tablets
• Manufactured By: Steris Healthcare Pvt Ltd
• Marketed By: Steris Healthcare Pvt Ltd
• Regulatory Standard: WHO-GMP Certified
• Drug Class: Non-Steroidal Anti-Androgen
• Schedule: Valid Prescription Required (Prescription Only)

How Does Bicalumutide 50 (Bicalutamide 50 mg) Work?

Bicalutamide 50 mg works by blocking androgen receptors in prostate cancer cells. Testosterone and dihydrotestosterone (DHT) are androgens that bind to receptors inside prostate cancer cells and trigger their growth. Bicalutamide competitively blocks these receptors, cutting off the hormonal signal that drives cancer cell multiplication.

Non-Steroidal Anti-Androgen Action

Unlike steroidal anti-androgens, bicalutamide is a pure androgen receptor antagonist. It does not lower testosterone levels in the blood — instead it prevents testosterone from acting on cancer cells at the receptor level. This selective action makes it well-tolerated for long-term use.

How It Slows Prostate Cancer:

• Binds to androgen receptors with high affinity, blocking testosterone access

• Prevents transcription of androgen-dependent genes that promote tumor growth

• Reduces PSA levels — a key marker of prostate cancer activity

• Slows tumor growth without completely suppressing natural testosterone production

• Works systemically, targeting cancer cells throughout the body

 

---

What Are the Benefits of Bicalumutide 50 Tablet?

Bicalumutide 50 offers proven anti-cancer benefits with a manageable tolerability profile compared to other hormonal therapies. Clinical studies show bicalutamide 150 mg monotherapy is comparable in survival outcomes to castration for locally advanced prostate cancer — and the 50 mg dose is widely validated in combination therapy protocols.

Key benefits of Bicalumutide 50 include:

• Effective tumor control — slows prostate cancer progression significantly

• PSA reduction — measurable decline in PSA levels within weeks of starting treatment

• Preserved sexual function — better quality of life vs surgical or medical castration

• Once-daily dosing — simple, convenient tablet taken once a day

• Well-established safety data — decades of clinical use across global oncology centers

• Combination flexibility — works effectively alongside LHRH agonists for advanced cases

• Oral administration — no injections, easy for outpatient and home-based therapy

 

---

How to Take Bicalumutide 50 Tablet

Take Bicalumutide 50 once daily at the same time every day. It can be taken with or without food. Consistent daily dosing maintains steady drug levels in the bloodstream, which is critical for sustained anti-cancer activity.

Important Instructions:

• Once daily — take at the same time each day, with or without a meal

• Swallow whole — do not crush, break, or chew the tablet

• Long-term therapy — continue as prescribed even if you feel well; stopping early can allow cancer to progress

• Combined therapy — if used with an LHRH analogue, both medicines should be started together as directed

• Missed dose — take as soon as you remember; never double the dose to compensate

• Alcohol — avoid excessive alcohol as it may interact with liver function during treatment

• Regular monitoring — routine PSA tests and liver function tests are required during therapy

 

---

Possible Side Effects of Bicalumutide 50 Tablet

Bicalumutide 50 is generally well tolerated but can cause hormonal and non-hormonal side effects in some patients. Most side effects are manageable and reduce over time with continued treatment.

Common Side Effects of Bicalutamide 50 mg Treatment

• Gynecomastia (breast tissue swelling) — the most commonly reported side effect due to androgen blockade

• Breast tenderness or pain — often accompanies gynecomastia, especially in the first months

• Hot flushes — sudden warmth and sweating, similar to menopausal symptoms

• Fatigue and weakness — mild tiredness is common in early treatment weeks

• Nausea — usually mild and improves after the first few weeks

• Liver enzyme elevation — rare but requires periodic liver function monitoring

• Anaemia — reduced red blood cell count in some patients on long-term therapy

• Decreased libido — reduced sexual desire due to androgen receptor blockade

Seek immediate medical attention if you notice yellowing of the skin or eyes, severe abdominal pain, or difficulty breathing — these may indicate rare but serious liver or lung reactions.

 

---

Where Can I Buy Bicalumutide 50 Tablets Online in India?

Bicalumutide 50 is available online in India through Steris Healthcare Pvt Ltd. As a trusted pharmaceutical manufacturer, Steris Healthcare supplies this bicalutamide 50 mg tablet to hospitals, oncology clinics, distributors, and healthcare providers across India with verified quality and regulatory compliance.

Why Buy Bicalumutide 50 from Steris Healthcare?

• WHO-GMP certified manufacturing — every batch quality tested

• Direct manufacturer pricing — no middlemen, competitive rates

• Pan-India supply network — reliable delivery across all states

• Prescription-based sales — responsible pharmaceutical distribution

• Dedicated oncology support team — expert guidance for healthcare providers

 

---

What Is the Cost of Bicalumutide 50 Tablet?

The cost of Bicalumutide 50 depends on quantity and purchase type. Steris Healthcare Pvt Ltd offers competitive institutional and retail pricing for bicalutamide 50 mg tablets in India. For the latest MRP, bulk purchase rates, or distributor pricing, contact Steris Healthcare directly through their official sales channel.

Pricing is subject to government MRP regulations and may vary by region and order volume.

---

What Are the Dosages of Bicalumutide 50? / Bicalutamide 50 mg Dosage for Adults

Bicalutamide 50 mg once daily is the standard adult dose for combination hormonal therapy in prostate cancer. Dosage varies based on the stage of cancer and whether it is used alone or with other treatments.

Bicalutamide Dosage for Adults

Indication	Recommended Dose	Frequency
Combined with LHRH analogue (advanced prostate cancer)	50 mg	Once daily
Monotherapy (locally advanced prostate cancer)	150 mg	Once daily
Rising PSA post-treatment	50 mg (as directed)	Once daily
Adjuvant therapy (early prostate cancer)	150 mg	Once daily

• Bicalumutide 50 is the 50 mg strength, suitable for combination therapy protocols

• Higher doses (150 mg) are used for monotherapy under specialist supervision

• Dose adjustments are not typically required for elderly patients or mild renal impairment

• Severe hepatic impairment may require dose review — always consult your oncologist

 

---

Why Choose Steris Healthcare for Quality Pharmaceutical Solutions?

Steris Healthcare Pvt Ltd is a WHO-GMP certified pharmaceutical company with a specialized portfolio covering oncology, cardiology, and metabolic medicines across India. With Bicalumutide 50 as part of their cancer care range, Steris Healthcare reflects a strong commitment to delivering affordable, high-quality life-saving medicines.

What Makes Steris Healthcare a Trusted Pharma Partner:

• WHO-GMP compliance — manufacturing meets international quality standards

• Oncology-focused portfolio — dedicated range of anti-cancer and hormonal therapy medicines

• Transparent product labeling — full composition, dosage, and safety information disclosed

• Nationwide distribution — hospitals, distributors, and retail pharmacies across India

• Affordable pricing — making critical cancer medicines accessible to more patients

• Experienced pharmaceutical team — formulation experts and medical professionals driving quality

Whether you're a hospital procurement manager, oncology distributor, or healthcare provider seeking a reliable bicalutamide 50 mg tablet supplier in India, Steris Healthcare Pvt Ltd is your trusted pharmaceutical partner.

 

---

Frequently Asked Questions (FAQs)

1. What is Bicalumutide 50 used for?

Ans. Bicalumutide 50 (bicalutamide 50 mg tablet) is used to treat prostate cancer in adult men. It works by blocking androgen receptors to stop testosterone from fueling cancer cell growth. It is used alone or combined with LHRH analogues for locally advanced and metastatic prostate cancer management.

2. How long should I take Bicalumutide 50?

Ans. Bicalumutide 50 is typically a long-term therapy continued for as long as it remains effective and tolerable. Your oncologist will determine the treatment duration based on PSA levels, cancer staging, and response to therapy. Never stop this medicine without consulting your doctor first.

3. How much bicalutamide should I take for prostate cancer?

Bicalutamide 50 mg once daily is the standard dose for prostate cancer. It belongs to a class of medicines called anti-androgens and works by blocking testosterone from reaching cancer cells. For combination therapy with LHRH analogues, 50 mg daily is prescribed. For monotherapy in locally advanced cases, the dose is increased to 150 mg once daily under oncologist supervision.

4. Does Bicalutamide Shrink Prostate Cancer?

Yes, bicalutamide can shrink prostate cancer tumors effectively. It belongs to a class of medicines called anti-androgens and works by blocking testosterone from reaching prostate cancer cells, which both slows cancer growth and can cause existing tumors to shrink. By starving cancer cells of the androgens they need to grow, bicalutamide helps reduce tumor size and lower PSA levels over time.

5. Can Bicalumutide 50 be taken without food?

Ans. Yes, Bicalumutide 50 can be taken with or without food. What matters most is taking it at the same time every day to maintain consistent drug levels in the bloodstream. A fixed daily routine — such as taking it with breakfast — helps with medication adherence.

6. What are the most common side effects of bicalutamide 50 mg?

Ans. The most commonly reported side effects of bicalutamide 50 mg include gynecomastia (breast tissue swelling), breast tenderness, hot flushes, and mild fatigue. These are related to androgen receptor blockade and are generally manageable. Liver function should be monitored periodically during treatment.

7. Who manufactures Bicalumutide 50 in India?

Ans. Bicalumutide 50 (bicalutamide 50 mg tablet) is manufactured by Hetero Labs limited and marketed by Steris Healthcare Pvt Ltd, a WHO-GMP certified pharmaceutical company in India. Steris Healthcare supplies this oncology medicine to hospitals, clinics, and distributors across India with guaranteed quality and regulatory compliance.